Addex convenes annual general meeting 2025

Geneva, switzerland, june 3, 2025 - addex therapeutics (six: adxn and nasdaq: adxn), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its 2025 annual general meeting will take place on tuesday june 24, 2025, at 11:00 am cest at the campus biotech, chemin des mines 9, 1202 geneva (doors open at 10:30 am).
GM Ratings Summary
GM Quant Ranking